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aBstraCt
introduCtion. The aim of the study is to compare classical vein imaging methods used to diagnose Age-related 
Macular Degeneration (AMD), like fluorescein angiography (FA), with non-invasive modern methods of ultrafast 
optical blood flow detection (Optical Coherence Tomography-angiography, Angio-OCT). 
Methods. Images obtained during examination using AF and Angio-OCT methods of four randomly selected 
patients treated for AMD in the Department of Ophthalmology Medical University of Silesia, Katowice, Poland 
were used for evaluation.
resuLts. Images obtained during routine check-up of patients treated for AMD were compared. 
ConCLusions. Angio-OCT is a non-invasive, non-contact, fast, and safe examination of patients treated for AMD. 
Angio-OCT is a modern method that provides important information about the progression of the disease, and it 
is used to evaluate retinal and choroidal vessels in patients with AMD.
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introduCtion
Age-related macular degeneration (AMD) is the 
leading cause of vision loss that affects people over 
50 years of age, occurring in 8.8% of the popula-
tion, more frequently among women [1, 2]. It is 
estimated that every tenth person over 45 years old 
is in the risk group of this disease. Optical Coher-
ence Tomography (OCT) is an imaging method 
that relies on receiving and processing of optical 
signals originating from sources that emit light hav-
ing a wide range of frequencies. OCT is a safe and 
non-invasive diagnostic method that does not re-
quire any substance to be added to the human body 
and does not expose it to radiation. Currently, OCT 
is used among other diagnostic tools for obtaining 
high-quality images of anterior segment of the eye 
and retinal disorders associated with the formation 
of fluid spaces (intraretinal fluid-IRF, subretinal flu-
id-SRF, or between the retinal pigment epithelium 
(RPE) and Bruch’s membrane-sub RPE fluid) [3]. 
The diseases most frequently diagnosed by using 
OCT include macular degeneration, diabetic retin-
opathy, and glaucoma. An extension of this tech-
nique is angiography OCT (OCT-angiography, 
Angio-OCT), which enables three-dimensional 
imaging of the retinal and choroidal vasculature 
without contrast [4]. Angio-OCT may be used in 
patients with age-related macular degeneration in 
order to qualify them for treatment [5]. The aim of 
the study is to compare classical methods of retinal 
vascular imaging such as fluorescein angiography 
(FA) with modern methods of ultrasound blood 
flow detection (Optical Coherence Tomography- 
angiography, Angio-OCT) in patients with AMD.
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MateriaLs and Methods
Images obtained during examination using AF, 
OCT, and Angio-OCT methods of four random-
ly selected patients (five eyes) treated for AMD 
in the Department of Ophthalmology Medical 
University of Silesia, Katowice, Poland were used 
for evaluation.
The study group embraced two women and 
two men aged from 49 to 90 years. Patients were 
treated with standard methods, and all performed 
tests were within the scope of routine check-ups 
in the treatment of AMD. Patients were informed 
about the exploitation of research results for sci-
entific purposes and signed a  consent required 
by law. The examination was performed using 
the following equipment: Topcon’s 3D OCT 
(OCT), Topcon’s Mark II TRC NW7SF (FA), 
and AngioVue from Optovue (Angio-OCT). All 
patients had best corrected visual acuity (BCVA) 
appraised. 
Figure 2. Patient 1. The OCT scan showing macular oedema and the fluid space is present (IRF and SRF)
Figure 1. Patient 1. Fluorescein angiography image showing increasing hyperfluorescence in latter stages
resuLts
Patient 1: a 79-year-old woman, right eye BCVA 
0.3. In fluorescein angiography there was increasing 
hyperfluorescence to the latter stages (Fig. 1). In op-
tical coherence tomography fluid spaces were pres-
ent in inner and outer layers of the retina (Fig. 2). 
In Angio-OCT the microvessels were visible in the 
choriocapillary layer (Fig. 3). Results obtained from 
this patient’s OCT and especially Angio-OCT ex-
aminations yielded more detailed information con-
cerning the changes in particular retinal layers and 
vessel structure. In comparison to fluorescein angi-
ography, Angio-OCT scans were characterised by 
higher resolution. 
Patient 2: a 58-year-old man, right BCVA 0.7. In 
fluorescein angiography we could observe increasing 
hyperfluorescence that covers pathological vessels, 
but in Angio-OCT the pathological microvessels 
were visible (Fig. 4). In comparison to fluoresce-
in angiography, Angio-OCT examination enabled 
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Figure 3. Patient 1. The Angio-OCT showing the same changes, and in the angio part there are micro vessels in the choriocapillary layer
Figure 4. Patient 2. Angio-OCT scans showing that the structure of the inner layer of the retina is homogenous; below there is extensive 
fluid space in the outer retina. In the picture of the angio-part we can see pathological vessels in the deep layer of the retina and the cho-
riocapillary layer
more precise evaluation of neovascular changes de-
spite minor signs of the disease. 
Patient 3: a  49-year-old man, left eye BCVA 
1.0 and right eye BCVA 0.7. The patient re-
ported himself to our clinic complaining about 
visual disorders in the right eye. Such disorders 
were not observed in the left eye (Figs. 5, 6). 
On OCT scans of the right eye we may observe 
loss of photoreceptors in macula. No chang-
es were observed in the left eye OCT scans. We 
observed clear pigment epithelium detachment 
(PED) on Angio-OCT scans using wide field op-
tions. In the choriocapillary layer there was an ex-
cellent visualisation of pathological vessels (Fig. 7). 
OCT examination enabled diagnosis of the loss of 
photoreceptors in the macula. Only Angio-OCT 
examination enabled diagnosis and evaluation of 
the extent and severity of blood leakage as well as 
the location of pathological vessels. Angio-OCT 
examination carried out in vivo enables precise 
functional evaluation of retinal vascular changes. 
Patient 4: a 90-year-old woman, right eye BCVA 
0.1, left eye BCVA 0.4. In fluorescein angiography 
there is increasing hyperfluorescence in the latter 
stages. In cases of fluorescein angiography, the hy-
perfluorescent area is visible covering the patholog-
ical vessels in the deeper layers of the retina whereas 
in Angio-OCT scans, thanks to the new possibilities 
of the device, excellent visualisation of microvessels 
in the choriocapillary layer was observed (Fig. 8). 
Fluorescein angiography appeared to be insufficient 
for examination of deeper retinal layers while An-
gio-OCT examination enabled evaluation of patho-
logical vessels covered by fluorescent dye.
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Figure 5. Patient 3. Comparison of OCT and FA. The patient has impaired vision in the right eye; there are no changes in eye fundus in 
the left eye; we can see the loss of the photoreceptors in macula in OCT in the right eye
Figure 6. Patient 3. On fluorescein angiography we did not observe any pathological changes in contrast flow and we did not observe 
any leakage from vessels, but in the left eye we can observe two points of hyperfluorescence peripheral and temporal to the macula
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Figure 7. Patient 3. The Angio-OCT scans confirm the presence of pathological vessels in choroid in the left eye and we can see Pigment 
Epithelial Detachment (PED) on the OCT scans. Right eye losses in Retinal Pigment Epithelium (RPE)
disCussion
A  recognised classic method of diagnosing 
retinal vessels is AF. In this method, it is nec-
essary to deliver a  fluorescent dye to the hu-
man body. As a  result of dye injection to the 
bloodstream the patient might be subject to 
side effects. Frequent complications associated 
with dye include: topical bleeding and petechi-
ae, infections, and local and generalised allergic 
reactions. Rare complications associated with 
contrast include: renal dysfunction, myocardial 
infarction or brain damage, blood vessels dam-
age through the cannula, or shock caused by 
an allergic or anaphylactic reaction. OCT and 
Angio-OCT are non-invasive and contactless test 
methods, so they can be used without exposing 
patients to complications [6, 7].
ConCLusions
Angio-OCT is a non-invasive, non-contact, fast, 
and safe examination of patients treated for AMD. 
Angio-OCT is a modern method that provides im-
portant information about the progression of retinal 
diseases and helps to evaluate the vascular network 
in patients suffering from AMD.
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Figure 8. Patient 4. Angio-OCT scans showing microvessels in the choriocapillary layer
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